NASDAQ:CERE

Cerevel Therapeutics Earning Date

USA |NASDAQ |USD

CERE Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 15, 2021 Sep 2021 $-0.39 $-0.42 $-0.15
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 15, 2021 Sep 2021 $0.00 $0.00 $0.00

Cerevel Therapeutics's next earnings date is Monday, Nov 15, 2021 for the fiscal quarter ending Sep 2021.

CERE Earnings Date & History Chart

CERE Earnings & Revenue Forecast

CERE Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-0.41 $-0.48 $-0.36
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-1.61 $-1.70 $-1.55
Dec 2022 4 $-1.76 $-2.08 $-1.49

CERE Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.41 $-0.40 $-0.41
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.61 $-1.60 $-1.59
Dec 2022 0 / 0 $-1.76 $-1.76 $-1.80

CERE Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 3 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $0.00 $0.00 $0.00
Dec 2022 4 $0.00 $0.00 $0.00

CERE Earnings Date & Revenue History

CERE Earnings History

|
Show More
Show More

CERE Revenue History

|
Show More
Show More

Cerevel Therapeutics Next Earnings Date & Report

CERE Next Earnings Date & Report Preview: Sep 2021 (FQ)

CERE's next earnings date is Monday, Nov 15, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 4 analysts, the average EPS estimation for Cerevel Therapeutics's next quarterly earnings is $-0.39, with a low EPS estimation of $-0.43, and a high estimation of $-0.36.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.39, the last 2 month trend is $-0.39, and the 3 month trend is $-0.39.

Based on 3 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Cerevel Therapeutics Previous Earnings Dates & Reports

CERE Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Cerevel Therapeutics's previous earnings date was Aug 11, 2021 for its fiscal quarter ended Jun 30, 2021.

CERE's earnings per share (EPS) was $-0.42, missing the consensus analysts forecast of $-0.39 by -7.69%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 5.00%.

Revenues were $0.00.

The company reported a net income of $-53.24M.

Free cash flow for the quarter was $-49.19M , compared to $-41.08M last quarter and $-28.05M a year before.

CERE ended the quarter with $35.14M in total debt, an increase of 0.15% compared to the previous quarter.

CERE Previous Earnings Date & Report Recap: Dec 2020 (FY)

Cerevel Therapeutics's previous annual earnings date was Mar 24, 2021 for its fiscal year ended Dec 31, 2020.

CERE's earnings per share (EPS) was $-0.42.

Revenues were $0.00.

The company reported a net income of $-152.14M.

Cerevel Therapeutics reported a free cash flow of $-136.69M for its fiscal year, compared to $-71.82M a year ago.

The company ended the fiscal year with $33.01M in total debt, an increase of 16.17% compared to the previous year.